Current status of cell-mediated regenerative therapies for human spinal cord injury

查看全文 作　　者：Tongming [1,2]Zhu;Qisheng [1,2]Tang;Huasong [1,2]Gao;Yiwen [1,2]Shen;Luping [1,2]Chen;Jianhong [1,2]Zhu

机构地区：[1]Department of Neurosurgery,Fudan University Huashan Hospital;[2]National Key Laboratory of Medical Neurobiology,Institutes of Brain Science,Shanghai Medical College,Fudan University

出　　处：《Neuroscience Bulletin》索引2014年第30卷第4期,共12页

基　　金：supported by grants from the National Natural Science Foundation of China (81271003);he National Basic Research Development Program (973 Program) of China (2010CB945500,2012CB966300,2009CB941100) 摘　　要：During the past decade, significant advances have been made in refinements for regenerative therapies following human spinal cord injury(SCI).Positive results have been achieved with different types of cells in various clinical studies of SCI.In this review, we summarize recently-completed clinical trials using cellmediated regenerative therapies for human SCI, together with ongoing trials using neural stem cells.Specifically, clinical studies published in Chinese journals are included.These studies show that current transplantation therapies are relatively safe, and have provided varying degrees of neurological recovery.However, many obstacles exist, hindering the introduction of a specifi c clinical therapy, including complications and their causes, selection of the target population, and optimization of transplantation material.Despite these and other challenges, with the collaboration of research groups and strong support from various organizations, cell-mediated regenerative therapies will open new perspectives for SCI treatment. 关键词：神经干细胞脊髓损伤疗法再生介导人类临床试验状态

相关文献

参考文献（82）
引证文献（7）
耦合文献（102）

参考文献(82)

引证文献(7)

耦合文献(102)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Current status of cell-mediated regenerative therapies for human spinal cord injury

参考文献(82)

引证文献(7)

耦合文献(102)

用户提示